XML 48 R37.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders’ Equity (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 13, 2024
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Common stock, shares authorized   25,000,000     25,000,000   25,000,000
Common stock, shares issued   10,784,725     10,784,725   10,721,192
Common stock, shares outstanding   10,784,725     10,784,725   10,721,192
Warrants to purchase shares of common stock   86,685     86,685    
Exercise of warrants         $ 66,710  
Number of shares issued   $ 11,994 $ 54,716        
Options were exercisable   960,785     960,785    
Weighted average exercise price, exercisable   $ 6.20     $ 6.20    
2018 Incentive Plan [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Number of shares issued $ 125,000            
Warrant [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Number of shares issued   2,088     22,220    
Cashless exercise warrants to purchase shares of common stock   7,664     7,664    
Warrants to purchase shares of common stock   70,000     70,000    
Number of shares issued   3,832     21,313    
Exercise of warrants   $ 11,994     $ 66,710    
Warrant exercise price   $ 18.75     $ 18.75    
Expiration date of warrants         Jun. 10, 2025    
Consultants [Member] | 2023 Restricted Common Stock [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Number of restricted shares           12,000  
Fair value of restricted shares           $ 63,000  
Expense   $ 0   $ 32,000 $ 0 $ 32,000  
Consultants [Member] | 2024 Restricted Common Stock [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Number of restricted shares         20,000    
Fair value of restricted shares         $ 81,000    
Expense   $ 0     $ 0